Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Healthcare Resource Utilization in Transplant Patients Who Are at a Higher-Risk to Develop Cytomegalovirus Infection during Their Primary Transplant-Related Hospitalization

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-143452

Published: 2020

Journal Articles

Updated Analysis: Novel Machine-Learning-Based Sepsis Prediction Model for Patients Undergoing Hematopoietic Stem Cell Transplantation (Early Sepsis Prediction/Identification for Transplant Recipients: ESPRIT)

Zahra Eftekhari, MS, Sally Mokhtari, PhD, Tushondra Thomas, MSN, MBA, PHN, RN-BC, Dongyun Yang, PhD, Liana Nikolaenko, MD, Deron Johnson, PharmD, Jana Dickter, MD, Justine Abella Ross, PharmD, Bernard Tegtmeier, PhD D(ABMM), CIC, Eileen P. Smith, MD, Monzr M. Al Malki, MD, Ricardo Spielberger, MD, Anna B Pawlowska, MD, Argelia Sandoval, MD, John Zaia, MD, Stephen J Forman, MD, Janet Munu, BSc, MBA, RN, Sanjeet Dadwal, MD, Ryotaro Nakamura, MD

Blood (2019) 134 (Supplement_1): 4477.

https://doi.org/10.1182/blood-2019-130926

Published: 2019

Journal Articles

Large-Scale Manufacturing of CMV-CD19CAR T Cells and Characterization of Their Biologic and Immunologic Properties

Xiuli Wang, PhD, Miriam Walter, Ryan Urak, Laura Lim, Vibhuti Vyas, MS, Sally Mokhtari, PhD, Don J. Diamond, PhD, Angelo Cardoso, PhD, John Zaia, MD, Stephen J. Forman, MD, Ryotaro Nakamura, MD

Blood (2019) 134 (Supplement_1): 3247.

https://doi.org/10.1182/blood-2019-131843

Published: 2019

Journal Articles

Incidence and Risk Factors of CMV Reactivation after Haploidentical Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide - Possible Role of Donor KIR Genotypes

Monzr Al Malki, MD, Sanjeet Dadwal, MD, Dongyun Yang, PhD, Sally Mokhtari, PhD, Thai Cao, MD, Ketevan Gendzekhadze, David S Snyder, MD, Haris Ali, MD, Ibrahim Aldoss, MD, Amandeep Salhotra, MD, Guido Marcucci, Chatchada Karanes, Pablo Parker, MD, Auayporn P. Nademanee, MDBS, Don Diamond, PhD, John Zaia, MD, Stephen J Forman, Ryotaro Nakamura, MD

Blood (2018) 132 (Supplement 1): 3416.

https://doi.org/10.1182/blood-2018-99-113514

Published: 2018

Journal Articles

High Incidence of CMV Reactivation after Haploidentical Donor Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide, and Its Impact on Transplant Outcomes

Monzr M. Al Malki, MD, Sanjeet Dadwal, MD, Dongyun Yang, PhD, Sally Mokhtari, PhD, Thai Cao, MD, Ketevan Gendzekhadze, PhD, Ibrahim Aldoss, MD, Pablo Parker, MD, Margaret R. O'Donnell, MD, David S. Snyder, MD, David Senitzer, PhD, Joseph Rosenthal, MD MS, Auayporn P. Nademanee, MDBS, Don Diamond, PhD, John Zaia, MD, Stephen J. Forman, MD FACP, Ryotaro Nakamura, MD

Blood (2017) 130 (Supplement 1): 4494.

https://doi.org/10.1182/blood.V130.Suppl_1.4494.4494

Published: 2017

Journal Articles

Enhanced Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV Specific Central Memory T Cells by CMV Vaccine.

Xiuli Wang, MD, PhD, Winnie Wong, B.S, Wen-Chung Chang, MS, Don Diamond, PhD, Michael C. Jensen, MD, Christine Brown, PhD, John Zaia, MD, Stephen J. Forman, MD

Blood (2012) 120 (21): 3014.

https://doi.org/10.1182/blood.V120.21.3014.3014

Published: 2012

Journal Articles

Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients

Myo Htut, MD, Ghislaine Gallez-Hawkins, Joycelynne Palmer, PhD, Xueli Liu, R. Spielberger, M.D., Pablo Parker, M.D., Len Farol, MD, Anne Franck, Xiuli Li, Jeannet Laëtitia, Eunicia Reburiano, Valerie Jimenez, Lupe Duarte, CCRC, Chatchada Karanes, MD, Stephen J. Forman, MD, John Zaia, MD, Amrita Krishnan, MD

Blood (2011) 118 (21): 5108.

https://doi.org/10.1182/blood.V118.21.5108.5108

Published: 2011

Journal Articles

Detection and Characterization of Antigen-Driven CD8 + T Lymphocytes Specific for Wilms' Tumor Antigen in Patients with Non-Hodgkin Lymphoma

Ryotaro Nakamura, MD, Anna Israyelyan, MD, PhD, Corinna La Rosa, PhD, Weimin Tsai, BS, Teodora Kaltcheva, PhD, Tumul Srivastava, PhD, Jessica Lo, BS, Lia Aquino, Jianqiang Li, PhD, Young Kim, MD, Joycelynne Palmer, PhD, David Senitzer, PhD, John Zaia, MD, Stephen J. Forman, MD, Don J. Diamond, PhD

Blood (2011) 118 (21): 953.

https://doi.org/10.1182/blood.V118.21.953.953

Published: 2011

Journal Articles

HIV Status Does Not Affect the Outcome of Autologous Stem Cell Transplantation (ASCT) for B Cell Non Hodgkin Lymphoma (NHL).

Amrita Krishnan, MD, FACP, John Zaia, MD, Joseph Alvarnas, MD, Neil Kogut, MD, Ricardo Spielberger, MD, Michelle Wardlow, RN, Nicole Tsai, MS, Tanya Paris, BS, Stephen J Forman, MD

Blood (2008) 112 (11): 2181.

https://doi.org/10.1182/blood.V112.11.2181.2181

Published: 2008

NARROW

Healthcare Resource Utilization in Transplant Patients Who Are at a Higher-Risk to Develop Cytomegalovirus Infection during Their Primary Transplant-Related Hospitalization

Updated Analysis: Novel Machine-Learning-Based Sepsis Prediction Model for Patients Undergoing Hematopoietic Stem Cell Transplantation (Early Sepsis Prediction/Identification for Transplant Recipients: ESPRIT)

Large-Scale Manufacturing of CMV-CD19CAR T Cells and Characterization of Their Biologic and Immunologic Properties

Incidence and Risk Factors of CMV Reactivation after Haploidentical Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide - Possible Role of Donor KIR Genotypes

High Incidence of CMV Reactivation after Haploidentical Donor Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide, and Its Impact on Transplant Outcomes

Enhanced Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV Specific Central Memory T Cells by CMV Vaccine.

Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients

Detection and Characterization of Antigen-Driven CD8 + T Lymphocytes Specific for Wilms' Tumor Antigen in Patients with Non-Hodgkin Lymphoma

HIV Status Does Not Affect the Outcome of Autologous Stem Cell Transplantation (ASCT) for B Cell Non Hodgkin Lymphoma (NHL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only